VRDN-003, Autoinjector — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07 (month) in 9d
ESTIMATED |
READOUT
A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants Wi
Phase 3 · Thyroid Eye Disease |
VRDN Viridian Therapeutics, Inc.D | VRDN-003, Autoinjector |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|